1-3 of 3
Tsutomu Hirano
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Chemerin-9, a potent agonist of chemerin receptor (ChemR23), prevents atherogenesis

Kengo Sato, Hayami Yoshizawa, Tomomi Seki, Remina Shirai, Tomoyuki Yamashita, Taisuke Okano, Koichiro Shibata, Miyu J. Wakamatsu, Yusaku Mori, Toshisuke Morita, Taka-aki Matsuyama, Hatsue Ishibashi-Ueda, Tsutomu Hirano, Takuya Watanabe
Journal: Clinical Science
Clin Sci (Lond) (2019) 133 (16): 1779–1796.
DOI: https://doi.org/10.1042/CS20190336
Published: 20 August 2019
View article
PDF
Includes: Supplementary data
Articles

Inhibitory effects of vasostatin-1 against atherogenesis

Yuki Sato, Rena Watanabe, Nozomi Uchiyama, Nana Ozawa, Yui Takahashi, Remina Shirai, Kengo Sato, Yusaku Mori, Takaaki Matsuyama, Hatsue Ishibashi-Ueda, Tsutomu Hirano, Takuya Watanabe
Journal: Clinical Science
Clin Sci (Lond) (2018) 132 (23): 2493–2507.
DOI: https://doi.org/10.1042/CS20180451
Published: 05 December 2018
View article
PDF
Includes: Supplementary data
Articles

Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes

Toshiaki Suguro, Takuya Watanabe, Syuusuke Kodate, Gang Xu, Tsutomu Hirano, Mitsuru Adachi, Akira Miyazaki
Journal: Clinical Science
Clin Sci (Lond) (2008) 115 (11): 327–334.
DOI: https://doi.org/10.1042/CS20080014
Published: 03 November 2008
View article
PDF